Latest news

Top 10 Skills Every Life Sciences Professional Needs in 2026

Executive Summary The life sciences industry in 2026 is undergoing a structural shift from function-driven expertise to capability-driven performance. As...

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Executive Summary Life sciences companies are reducing environmental impact across supply chains in 2026 by redesigning sourcing, manufacturing, and distribution...

How Is Generative AI Changing Drug Discovery in 2026?

Executive Summary Generative AI is fundamentally reshaping drug discovery in 2026 by shifting the process from iterative, lab-driven experimentation to...

The Rise of AI-Powered Clinical Trials: What Pharma Leaders Need to Know

Executive Summary AI-powered clinical trials are becoming a core operational strategy across pharma and biotech in 2026. Artificial intelligence is...

FDA chastises Alnylam for its efficacy claims on the Amvuttra website

The FDA's letter and warning to Alnylam (PDF) is...

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Bayer has agreed to acquire Perfuse Therapeutics in a deal that includes $300 million upfront and up to $2.15...

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Entrada Therapeutics reported early Phase 1/2 results for its Duchenne muscular dystrophy (DMD) candidate ENTR-601-44, showing a 2.36% increase...

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment to expand two of its three manufacturing facilities under development...

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Madrigal Pharmaceuticals has entered into a licensing agreement with...

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Viridian Therapeutics has reported success in a second phase...

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Robert Blum and Fady Malik have been with Cytokinetics since its inception almost 30 years ago. By achieving both...

Is Green Biotech the Future of Sustainable Drug Development?

Executive Summary Yes—green biotech is emerging as a foundational pillar of sustainable drug development in 2026. The shift is not...

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Amgen has announced an additional $300 million investment to expand its manufacturing operations in Puerto Rico, increasing its overall...

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Bayer has agreed to acquire Perfuse Therapeutics in a...

Popular

Most popular life news you must read today

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...

Regulatory

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Executive Summary Life sciences companies are reducing environmental impact across...

How Is Generative AI Changing Drug Discovery in 2026?

Executive Summary Generative AI is fundamentally reshaping drug discovery in...

The Rise of AI-Powered Clinical Trials: What Pharma Leaders Need to Know

Executive Summary AI-powered clinical trials are becoming a core operational...

Why Biotech Companies Are Rebuilding Their Data Strategies for AI

Executive Summary Biotech companies are rebuilding their data strategies in...

Research & Development

Market Access

Johnson & Johnson Agrees to MFN Drug Pricing and Expands U.S. Manufacturing Plans

Five months ago, Johnson & Johnson also announced plans...

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Major drugmakers have announced more than $370 billion in...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Top 10 Skills Every Life Sciences Professional Needs in 2026

Executive Summary The life sciences industry in 2026 is undergoing...

How Is Generative AI Changing Drug Discovery in 2026?

Executive Summary Generative AI is fundamentally reshaping drug discovery in...